Clene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. 

CEO
Robert Dee Etherington
CEORobert Dee Etherington
Employees
85
Employees85
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
85
Employees85

CLNN Key Statistics

Market cap
44.19M
Market cap44.19M
Price-Earnings ratio
-0.62
Price-Earnings ratio-0.62
Dividend yield
—
Dividend yield—
Average volume
2.51M
Average volume2.51M
High today
$0.355
High today$0.355
Low today
$0.3262
Low today$0.3262
Open price
$0.335
Open price$0.335
Volume
287.05K
Volume287.05K
52 Week high
$1.09
52 Week high$1.09
52 Week low
$0.25
52 Week low$0.25
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.